AIDS Clinical Trial Group (ACTG 5324) -- A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV

Grant

Date/time Interval

  • December 1, 2017 - November 30, 2018
  • Total Award Amount

  • 366370.00
  • Direct Costs

  • 246714.00
  • Sponsor Award Id

  • 110668
  • Contributor

  • Edward Acosta Pharm.D.   Principal Investigator